We were delighted to catch up with Prof Walter Ricciardi to discuss the EU Cancer Mission to improve the lives of over 3 million people by 2030 through prevention, cure and for those affected by cancer including their families, to live longer and better.
1. What is the goal of the Mission on Cancer? 00:17-01:00
2. What are the five intervention areas of the mission? 01:03-01:50
3. Could you give us a brief overview of the major recommendations? 01:50-02:55
4. What is the role of the Mission Board for Cancer? 02:55-03:35
5. How will progress be assessed? 03:35-04:00
Speaker Disclosure: Prof Walter Ricciardi has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the European Cancer Summit 2021
Share this Video
Related Videos In Policy
Mark Lawler, European Cancer Summit 2022: The ECO-ASCO Special Network
The impact of the Russian invasion on Ukraine and how this has impacted clinical trials and cancer care in Europe. The Special Network on the Impact of the War in Ukraine on Cancer was established by ECO Board and ASCO soon after the war started, and now has representatives of over 300 organisations. In this […]
Mark Lawler, European Cancer Summit, 2022: What is the European Cancer Pulse?
Professor Mark Lawler (Queen’s University Belfast) summarizes the European Cancer Pulse, an exciting new tool that brings together data from 34 European countries and helps determine cancer care disparities on cancer burden, research spending, prevention efforts, early detection, diagnosis and treatment access, survivorship, impact of social determinants and much more. For more information, click here. […]
Mark Lawler, European Cancer Summit 2022: The European Groundshot
The European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission is a unique imitative launched this year aims to identify the challenges in cancer care in Europe. The COVID-19 pandemic has had a significant impact on cancer diagnosis and halted many ongoing clinical trials. In this video, Professor Mark Lawler (Queen’s University Belfast) describes […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!